Fermata Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,898
Closed -$410K 262
2025
Q1
$410K Buy
+5,898
New +$410K 0.07% 182
2024
Q4
Sell
-3,847
Closed -$458K 280
2024
Q3
$458K Buy
3,847
+152
+4% +$18.1K 0.09% 131
2024
Q2
$527K Buy
3,695
+1,361
+58% +$194K 0.12% 107
2024
Q1
$300K Buy
+2,334
New +$300K 0.07% 163